Authors:
KWON JT
KIM HK
KIM HS
CHUNG IK
PARK SH
KIM SJ
SOHN DR
Citation: Jt. Kwon et al., THE GENETIC-POLYMORPHISM OF CYP2E1 IN KOREAN HEALTHY-SUBJECTS AND HEPATOCELLULAR-CARCINOMA PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 41-41
Citation: Hk. Kim et al., DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY AND PLASMA 5-FLUOROURACIL LEVELS IN KOREAN SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 54-54
Citation: Dr. Sohn et al., METABOLIC DISPOSITION OF LANSOPRAZOLE IN RELATION TO THE S-MEPHENYTOIN 4'-HYDROXYLATION PHENOTYPE STATUS, Clinical pharmacology and therapeutics, 61(5), 1997, pp. 574-582
Citation: Jt. Kwon et al., THE FREQUENCY OF THE 2 MUTATED ALLELES, CYP2C19(M1) AND CYP2C19(M2), IN A KOREAN POPULATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 81-81
Citation: Dr. Sohn et al., INFLUENCE OF S-MEPHENYTOIN PHENOTYPE ON THE LANSOPRAZOLE METABOLISM, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 34-34
Citation: Jh. Lee et al., CYCLOBUXINE PROTECTS THE ISOLATED RAT-HEART FROM THE MYOCARDIAL INJURIES PRODUCED BY ISCHEMIA AND REPERFUSION, Planta medica, 59(4), 1993, pp. 296-301